As if we needed yet another reason to despise big business, drug companies use various legal (though maybe not ethical) measures to keep profits high by
preventing the introduction of generics in Europe. At least the European Commission sounds like they're willing to go after them if they break the law in the process; in the U.S., we just shovel more money at them through Medicare Part D and call it progress.
No comments:
Post a Comment